Understanding the molecular causes of Parkinson's disease
Top Cited Papers
- 1 November 2006
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 12 (11) , 521-528
- https://doi.org/10.1016/j.molmed.2006.09.007
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- α-Synuclein Cooperates with CSPα in Preventing NeurodegenerationCell, 2005
- Dopamine covalently modifies and functionally inactivates parkinNature Medicine, 2005
- Double-knockout mice for α- and β-synucleins: Effect on synaptic functionsProceedings of the National Academy of Sciences, 2004
- Structural Determinants of PLD2 Inhibition by α-SynucleinJournal of Molecular Biology, 2004
- Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson?s diseaseJournal of Molecular Medicine, 2004
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- Vesicle Permeabilization by Protofibrillar α-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson's DiseaseBiochemistry, 2001
- Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformationProceedings of the National Academy of Sciences, 2000
- Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine SystemNeuron, 2000
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997